Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALGN · against 158 other Healthcare companies of similar size
Ranked #106 of 159 · scores higher than 34% of peers · safety percentile 28
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)18 peers with a safety percentile of 20–29, including ALGN · Click a bar to see the companies
Mainly because of its beta and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ALGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 153 reported | 0.03× | 0.35× | 85% | 33% | |
| BetaLower is better · 161 reported | 1.67 | 0.58 | 9% | 33% | |
| Current ratioHigher is better · 150 reported | 1.40× | 2.30× | 23% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 5.7B USD | 97 | 52 | |
| 102 | 2.57T JPY (≈$17.5B) | 30 | 62 | |
| 103 | 15.7B USD | 29 | 33 | |
| 104 | 64.1B CNY (≈$9.0B) | 29 | 48 | |
| 105 | 69.1B BRL (≈$12.4B) | 29 | 57 | |
| 106 | 10.8B USD | 28 | 54 | |
| 107 | 18.2B USD | 28 | 40 | |
| 108 | 14.9B USD | 28 | 65 | |
| 109 | 9.7B AUD (≈$6.4B) | 27 | 52 | |
| 110 | 7.2B USD | 26 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score